Developer of molecular diagnostic and freeze dried technology designed to offer both custom manufacturing services and molecular diagnostic products. The company's molecular diagnostic and freeze dried technology offers complete freeze-dried PCR tests targeted at the transplantation, pharmacogenetic and disease identification markets, enabling users to get complete amplification and immunoassays to be transformed into instantly soluble freeze-dried pellets. read more
Biofortuna CEO & Leadership Team Ratings
Simon Douglas and the Biofortuna leadership team are scored a "C" by 4 employees placing it in the Bottom 40% of companies sized 11-50 Employees. The Leadership Score of 68/100 is based on 12 ratings; it combines employee feedback on their CEO (70/100), Manager (67/100), and Executive Team (67/100).
Simon Douglas Biofortuna CEO Rating
Top 50% Compared to other companies of similar sizeC+
70 / 100
Simon Douglas the CEO of Biofortuna received an average score of 70 from Biofortuna employees.Biofortuna Manager Rating
Bottom 35% Compared to other companies of similar sizeC-
67 / 100
Biofortuna Executive Team Rating
Bottom 40% Compared to other companies of similar sizeC
67 / 100
×